These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3019376)

  • 1. Burkitt-like lymphoma in an English child: characterisation of tumour biopsy cells and of the derived tumour cell line.
    Finerty S; Rowe M; Berry PJ; Ranson DL; Mott MG; Gregory CD; Rickinson AB
    Br J Cancer; 1986 Sep; 54(3):385-91. PubMed ID: 3019376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinctions between endemic and sporadic forms of Epstein-Barr virus-positive Burkitt's lymphoma.
    Rowe M; Rooney CM; Rickinson AB; Lenoir GM; Rupani H; Moss DJ; Stein H; Epstein MA
    Int J Cancer; 1985 Apr; 35(4):435-41. PubMed ID: 2985508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus status and tumour cell phenotype in sporadic Burkitt's lymphoma.
    Rowe M; Rooney CM; Edwards CF; Lenoir GM; Rickinson AB
    Int J Cancer; 1986 Mar; 37(3):367-73. PubMed ID: 3005176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
    Gregory CD; Rowe M; Rickinson AB
    J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells.
    Rowe M; Rowe DT; Gregory CD; Young LS; Farrell PJ; Rupani H; Rickinson AB
    EMBO J; 1987 Sep; 6(9):2743-51. PubMed ID: 2824192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production by EBV infection of an EBNA-positive subline from an EBNA-negative human lymphoma cell line without detectable EBV DNA.
    Clements GB; Klein G; Povey S
    Int J Cancer; 1975 Jul; 16(1):125-33. PubMed ID: 170210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas.
    Young LS; Yao QY; Rooney CM; Sculley TB; Moss DJ; Rupani H; Laux G; Bornkamm GW; Rickinson AB
    J Gen Virol; 1987 Nov; 68 ( Pt 11)():2853-62. PubMed ID: 2824665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and characterization of a new human Burkitt's lymphoma cell line (WSU-BL).
    Mohamed AN; Mohammad RM; Koop BF; al-Katib A
    Cancer; 1989 Sep; 64(5):1041-8. PubMed ID: 2527086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Epstein-Barr virus-negative B lymphoma cell line (THP-2) from a Burkitt's lymphoma of a Japanese patient.
    Tsuchiya S; Yamaguchi Y; Kobayashi Y; Minegishi M; Imaizumi M; Suzuki H; Konno T; Tada K
    Tohoku J Exp Med; 1983 Aug; 140(4):429-34. PubMed ID: 6314596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burkitt's lymphoma cell line bearing surface IgA and negative for nuclear antigen of Epstein-Barr virus (EBNA).
    Hayashi Y; Matsumura Y; Nishihira T; Watanabe I; Ohi R; Kasai M; Kumagai K; Kamada N
    Jpn J Exp Med; 1980 Dec; 50(6):423-34. PubMed ID: 6268866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
    Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variant translocation in a non endemic case of Burkitt's lymphoma: t (8;22) in an Epstein--Barr virus negative tumour and in a derived cell line.
    Bertrand S; Berger R; Philip T; Bernheim A; Bryon PA; Bertoglio J; Doré JF; Brunat-Mentigny M; Lenoir GM
    Eur J Cancer (1965); 1981 May; 17(5):577-84. PubMed ID: 6271555
    [No Abstract]   [Full Text] [Related]  

  • 14. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
    Schaefer BC; Woisetschlaeger M; Strominger JL; Speck SH
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6550-4. PubMed ID: 1713681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface marker characteristics and Epstein-Barr virus studies of two established North American Burkitt's lymphoma cell lines.
    Epstein AL; Henle W; Henle G; Hewetson JF; Kaplan HS
    Proc Natl Acad Sci U S A; 1976 Jan; 73(1):228-32. PubMed ID: 174098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome translocations, surface immunoglobulins, and Epstein-Barr virus in Japanese Burkitt's lymphoma.
    Sakurai M; Hayashi Y; Abe R; Nakazawa S
    Cancer Genet Cytogenet; 1983 Mar; 8(3):275-6. PubMed ID: 6297707
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of Japanese Burkitt's lymphoma associated with EB virus.
    Shikano T; Ueno N; Matsumoto T; Ohkawa M; Tono-Oka T; Okano M; Yano S; Osato T
    Jpn J Clin Oncol; 1984 Sep; 14(3):445-50. PubMed ID: 6090736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The establishment of Epstein-Barr virus nuclear antigen-positive (SP-50B) and Epstein-Barr virus nuclear antigen-negative (SP-53) cell lines with t(11;14)(q13;q32) chromosome abnormality from an intermediate lymphocytic lymphoma.
    Daibata M; Kubonishi I; Eguchi T; Yano S; Ohtsuki Y; Miyoshi I
    Cancer; 1989 Sep; 64(6):1248-53. PubMed ID: 2548699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential activation of cytotoxic responses by Burkitt's lymphoma (BL)-cell lines: relationship to the BL-cell surface phenotype.
    Rooney CM; Edwards CF; Lenoir GM; Rupani H; Rickinson AB
    Cell Immunol; 1986 Oct; 102(1):99-112. PubMed ID: 3026651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new Epstein-Barr virus negative Burkitt's lymphoma derived cell-line. I. Analysis of cell surface markers and abnormal expression of HLA antigens.
    Kalil J; Fellous M; Tanigaki N; Rosa F; Pagniez C; Herzog C; Dastot H; Lenoir G
    Tissue Antigens; 1982 Jul; 20(1):47-62. PubMed ID: 6289490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.